Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Tohid Khadem Amiri & Rezvan Salehidoost. (2023) Anabolic-androgenic steroid use among Iranian male gym-goers. Journal of Substance Use 28:6, pages 925-929.
Read now
Read now
Luke Cox, Nick Gibbs & Luke A Turnock. (2023) “Emerging anabolic androgenic steroid markets; the prominence of social media”. Drugs: Education, Prevention and Policy 0:0, pages 1-14.
Read now
Read now
Evelyn Hearne, Amanda Atkinson, Ian Boardley, Jim McVeigh & Marie Claire Van Hout. (2022) ‘Sustaining masculinity’: a scoping review of anabolic androgenic steroid use by older males. Drugs: Education, Prevention and Policy 0:0, pages 1-27.
Read now
Read now
Vassilis Barkoukis, Stela Kaffe, Amanda Atkinson, Harry Sumnall, Jukka Koskelo, Hanna-Kaisa Jussila, Kristina Jagminiene & Ruta Banyte. (2022) Fitness professionals’ perceptions of acceptability and usability of anti-doping education tools for recreational sports. Drugs: Education, Prevention and Policy 29:6, pages 726-736.
Read now
Read now
Vivian D. Hope, Vincent Walker Bond, Ian Boardley, Josie Smith, John Campbell, Geoff Bates, Rob Ralphs, Marie-Claire Van Hout & Jim McVeigh. (2022) Anabolic androgenic steroid use population size estimation: a first stage study utilising a Delphi exercise. Drugs: Education, Prevention and Policy 0:0, pages 1-13.
Read now
Read now
Katinka van de Ven, Ian Boardley & Martin Chandler. (2022) Identifying best-practice amongst health professionals who work with people using image and performance enhancing drugs (IPEDs) through participatory action research. Qualitative Research in Sport, Exercise and Health 14:2, pages 199-215.
Read now
Read now
Sadat Abdulla Aziz. (2022) Attitude and health issue awareness of anabolic androgenic steroids use among male gym users in some gym centers in Sulaymaniyah city, Iraq. Journal of Substance Use 27:1, pages 14-19.
Read now
Read now
April Henning & Jesper Andreasson. (2022) Preventing, producing, or reducing harm? Fitness doping risk and enabling environments. Drugs: Education, Prevention and Policy 29:1, pages 95-104.
Read now
Read now
Bengt Kayser & Andreas De Block. (2021) Would Relaxation of the Anti-doping Rule Lead to Red Queen Effects?. Sport, Ethics and Philosophy 15:3, pages 371-385.
Read now
Read now
Orlanda Harvey & Margarete Parrish. (2020) Social Work Implications of Anabolic–Androgenic Steroid Use, Particularly Among Young People: A Literature Review. Practice 32:3, pages 209-228.
Read now
Read now
Geoff Bates, David Tod, Conan Leavey & Jim McVeigh. (2019) An evidence-based socioecological framework to understand men’s use of anabolic androgenic steroids and inform interventions in this area. Drugs: Education, Prevention and Policy 26:6, pages 484-492.
Read now
Read now
Orlanda Harvey. (2019) ‘Shades of Grey’: The Ethics of Social Work Practice in Relation to Un-prescribed Anabolic Androgenic Steroid Use. Practice 31:4, pages 239-258.
Read now
Read now
Articles from other publishers (23)
Mohammadreza Rabiee & Masoumeh Sadat Mousavi. (2023) Tendency to Consume Anabolic Steroids and Body-Building Supplements in the General Population: An Ecological Study. International Journal of Sport Studies for Health 6:2.
Crossref
Crossref
Luke A. Turnock & Kyle J. D. Mulrooney. (2023) Exploring the Impacts of Rurality on Service Access and Harm Among Image and Performance Enhancing Drug (IPED) Users in a Remote English Region. Contemporary Drug Problems 50:2, pages 232-253.
Crossref
Crossref
Michael Petrou & Lambros Lazuras. (2023) Comment on “Recreational Athletes’ Use of Performance‑Enhancing Substances: Results from the First European Randomized Response Technique Survey”. Sports Medicine - Open 9:1.
Crossref
Crossref
Alex Davies, Michael Sangiorgio & Ashwin Patwardhan. (2023) Multiple Small Bowel Intussusceptions in the setting of Anabolic Steroid Use. Journal of Gastrointestinal and Abdominal Radiology.
Crossref
Crossref
Tjeerd Idger de Zeeuw, Tibor Markus Brunt, Jan van Amsterdam, Katinka van de Ven & Wim van den Brink. (2023) Anabolic Androgenic Steroid Use Patterns and Steroid Use Disorders in a Sample of Male Gym Visitors. European Addiction Research 29:2, pages 99-108.
Crossref
Crossref
Luke A. Turnock. (2022) Exploring user narratives of self-medicated black market IPED use for therapeutic & wellbeing purposes. Performance Enhancement & Health 10:2, pages 100207.
Crossref
Crossref
Ingo Butzke, Samuel Iff, Michael Zitzmann, Boris B. Quednow & Malte Christian Claussen. (2022) Interdisciplinary and Psychiatric Treatment of Anabolic Androgenic Steroids Users. Praxis 111:6, pages e339-e344.
Crossref
Crossref
Ingo Butzke, Samuel Iff, Michael Zitzmann, Boris B. Quednow & Malte Christian Claussen. (2022) Interdisziplinäre und psychiatrisch-psychotherapeutische Behandlung bei Gebrauch von anabolen androgenen Steroiden. Praxis 111:6, pages 339-344.
Crossref
Crossref
Jim McVeigh & Geoff Bates. 2022. Drugs, Identity and Stigma. Drugs, Identity and Stigma
121
146
.
Jim McVeigh, Evelyn Hearne, Ian Boardley, Geoff Bates, Vivian Hope, Rob Ralphs & Marie Claire Van Hout. (2021) Generating evidence on the use of Image and performance enhancing drugs in the UK: results from a scoping review and expert consultation by the Anabolic Steroid UK network. Harm Reduction Journal 18:1.
Crossref
Crossref
Matthew Peter Hibbert, Caroline E. Brett, Lorna A. Porcellato & Vivian D. Hope. (2021) Image and performance enhancing drug use among men who have sex with men and women who have sex with women in the UK. International Journal of Drug Policy 95, pages 102933.
Crossref
Crossref
Luke A. Turnock. (2021) Rural gym spaces and masculine physical cultures in an ‘age of change’: Rurality, masculinity, inequalities and harm in ‘the gym’. Journal of Rural Studies 86, pages 106-116.
Crossref
Crossref
Evelyn Hearne, Mayyada Wazaify, Marie Claire Van Hout, Amanda Atkinson & Jim McVeigh. (2020) Anabolic-Androgenic Steroid Use in the Eastern Mediterranean Region: a Scoping Review of Extant Empirical Literature. International Journal of Mental Health and Addiction 19:4, pages 1162-1189.
Crossref
Crossref
Bertrand Fincoeur & Jessica Rullo. (2021) Je pousse donc je suis : du rôle de la musculation et des produits de la performance en prison. Déviance et Société Vol. 45:2, pages 231-263.
Crossref
Crossref
Luke A. Turnock. (2021) Polydrug use and drug market intersections within powerlifting cultures in remote South-West England. Performance Enhancement & Health 8:4, pages 100186.
Crossref
Crossref
Hagit Bonny-Noach, Ronny Berkovitz & Barak Shapira. (2020) Evaluation of performance-enhancing drugs seized by Israeli enforcement agencies 2012–2017: implications for policy and regulatory change. Israel Journal of Health Policy Research 9:1.
Crossref
Crossref
Katharina R. Beck, George R. ThompsonIIIIII & Alex Odermatt. (2020) Drug-induced endocrine blood pressure elevation. Pharmacological Research 154, pages 104311.
Crossref
Crossref
Luke A. Turnock. (2020) Inside a steroid ‘brewing’ and supply operation in South-West England: An ‘ethnographic narrative case study’. Performance Enhancement & Health 7:3-4, pages 100152.
Crossref
Crossref
Kyle J.D Mulrooney, Katinka van de Ven, Jim McVeigh & Rick Collins. (2019) Steroid Madness- has the dark side of anabolic-androgenic steroids (AAS) been over-stated?. Performance Enhancement & Health 6:3-4, pages 98-102.
Crossref
Crossref
Mike Salinas, William Floodgate & Rob Ralphs. (2019) Polydrug use and polydrug markets amongst image and performance enhancing drug users: Implications for harm reduction interventions and drug policy. International Journal of Drug Policy 67, pages 43-51.
Crossref
Crossref
Katinka Van de Ven, Lisa Maher, Handan Wand, Sonja Memedovic, Eva Jackson & Jenny Iversen. (2018) Health risk and health seeking behaviours among people who inject performance and image enhancing drugs who access needle syringe programs in Australia. Drug and Alcohol Review 37:7, pages 837-846.
Crossref
Crossref
Dominic Sagoe & Ståle Pallesen. (2018) Androgen abuse epidemiology. Current Opinion in Endocrinology, Diabetes & Obesity 25:3, pages 185-194.
Crossref
Crossref
Lindsey J. Anderson, Jamie M. Tamayose & Jose M. Garcia. (2018) Use of growth hormone, IGF-I, and insulin for anabolic purpose: Pharmacological basis, methods of detection, and adverse effects. Molecular and Cellular Endocrinology 464, pages 65-74.
Crossref
Crossref